Linagliptin in Schizophrenia Patients

NCT01943019 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Inability to obtain patients

Conditions

Schizophrenia

Interventions

DRUG: Linagliptin

Sponsor

Monash University

Collaborators

[object Object]